PD-1-Targeted Discovery of Peptide Inhibitors by Virtual Screening, Molecular Dynamics Simulation, and Surface Plasmon Resonance

The blockade of the programmed cell death protein 1/programmed cell death ligand 1 (PD-1/PD-L1) pathway plays a critical role in cancer immunotherapy by reducing the immune escape. Five monoclonal antibodies that antagonized PD-1/PD-L1 interaction have been approved by the Food and Drug Administrati...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuanqiang, Guo, Haiqiong, Feng, Zhiwei, Wang, Siyi, Wang, Yuxuan, He, Qingxiu, Li, Guangping, Lin, Weiwei, Xie, Xiang-Qun, Lin, Zhihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6833008/
https://www.ncbi.nlm.nih.gov/pubmed/31640203
http://dx.doi.org/10.3390/molecules24203784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6833008/
https://www.ncbi.nlm.nih.gov/pubmed/31640203
http://dx.doi.org/10.3390/molecules24203784

Ejemplares similares